Quality of Care Provided by Board-Certified Versus Non-Board-Certified Psychiatrists and Neurologists

Anna Wallace, Bentson McFarland, Nandini Selvam, Gurvaneet Sahota

Research output: Contribution to journalArticle

Abstract

PURPOSE: To examine associations between board certification of psychiatrists and neurologists and quality-of-care measures, using multilevel models controlling for physician and patient characteristics, and to assess feasibility of linking physician information with patient records to construct quality measures from electronic claims data. METHOD: The authors identified quality measures and matched claims data from 2006 to 2012 with 942 board-certified (BC) psychiatrists, 868 non-board-certified (nBC) psychiatrists, 963 BC neurologists, and 328 nBC neurologists. Using the matched data, they identified psychiatrists who treated at least one patient with a schizophrenia diagnosis, and neurologists attending patients discharged with a principal diagnosis of ischemic stroke, and analyzed claims from these patients. For patients with schizophrenia who were prescribed an atypical antipsychotic, quality measures were claims for glucose and lipid tests, duration of any antipsychotic treatment, and concurrent prescription of multiple antipsychotics. For patients with ischemic stroke, quality measures were dysphagia evaluation; speech/language evaluation; and prescription of clopidogrel, low-molecular-weight heparin, intravenous heparin, and warfarin (for patients with co-occurring atrial fibrillation). RESULTS: Overall, multilevel models (patients nested within physicians) showed no statistically significant differences in quality measures between BC and nBC psychiatrists and neurologists. CONCLUSIONS: The authors demonstrated the feasibility of linking physician information with patient records to construct quality measures from electronic claims data, but there may be only minimal differences in the quality of care between BC and nBC psychiatrists and neurologists, or there may be a difference that could not be measured with the quality measures used.

Original languageEnglish (US)
JournalAcademic Medicine
DOIs
StateAccepted/In press - May 17 2016

Fingerprint

Quality of Health Care
psychiatrist
Psychiatry
physician
Antipsychotic Agents
Physicians
schizophrenia
stroke
clopidogrel
medication
Prescriptions
Schizophrenia
electronics
Stroke
Neurologists
Low Molecular Weight Heparin
evaluation
Certification
Warfarin
Deglutition Disorders

ASJC Scopus subject areas

  • Medicine(all)
  • Education

Cite this

Quality of Care Provided by Board-Certified Versus Non-Board-Certified Psychiatrists and Neurologists. / Wallace, Anna; McFarland, Bentson; Selvam, Nandini; Sahota, Gurvaneet.

In: Academic Medicine, 17.05.2016.

Research output: Contribution to journalArticle

Wallace, Anna ; McFarland, Bentson ; Selvam, Nandini ; Sahota, Gurvaneet. / Quality of Care Provided by Board-Certified Versus Non-Board-Certified Psychiatrists and Neurologists. In: Academic Medicine. 2016.
@article{8b18e155ea6b46f590d46cf934c1aba3,
title = "Quality of Care Provided by Board-Certified Versus Non-Board-Certified Psychiatrists and Neurologists",
abstract = "PURPOSE: To examine associations between board certification of psychiatrists and neurologists and quality-of-care measures, using multilevel models controlling for physician and patient characteristics, and to assess feasibility of linking physician information with patient records to construct quality measures from electronic claims data. METHOD: The authors identified quality measures and matched claims data from 2006 to 2012 with 942 board-certified (BC) psychiatrists, 868 non-board-certified (nBC) psychiatrists, 963 BC neurologists, and 328 nBC neurologists. Using the matched data, they identified psychiatrists who treated at least one patient with a schizophrenia diagnosis, and neurologists attending patients discharged with a principal diagnosis of ischemic stroke, and analyzed claims from these patients. For patients with schizophrenia who were prescribed an atypical antipsychotic, quality measures were claims for glucose and lipid tests, duration of any antipsychotic treatment, and concurrent prescription of multiple antipsychotics. For patients with ischemic stroke, quality measures were dysphagia evaluation; speech/language evaluation; and prescription of clopidogrel, low-molecular-weight heparin, intravenous heparin, and warfarin (for patients with co-occurring atrial fibrillation). RESULTS: Overall, multilevel models (patients nested within physicians) showed no statistically significant differences in quality measures between BC and nBC psychiatrists and neurologists. CONCLUSIONS: The authors demonstrated the feasibility of linking physician information with patient records to construct quality measures from electronic claims data, but there may be only minimal differences in the quality of care between BC and nBC psychiatrists and neurologists, or there may be a difference that could not be measured with the quality measures used.",
author = "Anna Wallace and Bentson McFarland and Nandini Selvam and Gurvaneet Sahota",
year = "2016",
month = "5",
day = "17",
doi = "10.1097/ACM.0000000000001233",
language = "English (US)",
journal = "Academic Medicine",
issn = "1040-2446",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Quality of Care Provided by Board-Certified Versus Non-Board-Certified Psychiatrists and Neurologists

AU - Wallace, Anna

AU - McFarland, Bentson

AU - Selvam, Nandini

AU - Sahota, Gurvaneet

PY - 2016/5/17

Y1 - 2016/5/17

N2 - PURPOSE: To examine associations between board certification of psychiatrists and neurologists and quality-of-care measures, using multilevel models controlling for physician and patient characteristics, and to assess feasibility of linking physician information with patient records to construct quality measures from electronic claims data. METHOD: The authors identified quality measures and matched claims data from 2006 to 2012 with 942 board-certified (BC) psychiatrists, 868 non-board-certified (nBC) psychiatrists, 963 BC neurologists, and 328 nBC neurologists. Using the matched data, they identified psychiatrists who treated at least one patient with a schizophrenia diagnosis, and neurologists attending patients discharged with a principal diagnosis of ischemic stroke, and analyzed claims from these patients. For patients with schizophrenia who were prescribed an atypical antipsychotic, quality measures were claims for glucose and lipid tests, duration of any antipsychotic treatment, and concurrent prescription of multiple antipsychotics. For patients with ischemic stroke, quality measures were dysphagia evaluation; speech/language evaluation; and prescription of clopidogrel, low-molecular-weight heparin, intravenous heparin, and warfarin (for patients with co-occurring atrial fibrillation). RESULTS: Overall, multilevel models (patients nested within physicians) showed no statistically significant differences in quality measures between BC and nBC psychiatrists and neurologists. CONCLUSIONS: The authors demonstrated the feasibility of linking physician information with patient records to construct quality measures from electronic claims data, but there may be only minimal differences in the quality of care between BC and nBC psychiatrists and neurologists, or there may be a difference that could not be measured with the quality measures used.

AB - PURPOSE: To examine associations between board certification of psychiatrists and neurologists and quality-of-care measures, using multilevel models controlling for physician and patient characteristics, and to assess feasibility of linking physician information with patient records to construct quality measures from electronic claims data. METHOD: The authors identified quality measures and matched claims data from 2006 to 2012 with 942 board-certified (BC) psychiatrists, 868 non-board-certified (nBC) psychiatrists, 963 BC neurologists, and 328 nBC neurologists. Using the matched data, they identified psychiatrists who treated at least one patient with a schizophrenia diagnosis, and neurologists attending patients discharged with a principal diagnosis of ischemic stroke, and analyzed claims from these patients. For patients with schizophrenia who were prescribed an atypical antipsychotic, quality measures were claims for glucose and lipid tests, duration of any antipsychotic treatment, and concurrent prescription of multiple antipsychotics. For patients with ischemic stroke, quality measures were dysphagia evaluation; speech/language evaluation; and prescription of clopidogrel, low-molecular-weight heparin, intravenous heparin, and warfarin (for patients with co-occurring atrial fibrillation). RESULTS: Overall, multilevel models (patients nested within physicians) showed no statistically significant differences in quality measures between BC and nBC psychiatrists and neurologists. CONCLUSIONS: The authors demonstrated the feasibility of linking physician information with patient records to construct quality measures from electronic claims data, but there may be only minimal differences in the quality of care between BC and nBC psychiatrists and neurologists, or there may be a difference that could not be measured with the quality measures used.

UR - http://www.scopus.com/inward/record.url?scp=84969179533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969179533&partnerID=8YFLogxK

U2 - 10.1097/ACM.0000000000001233

DO - 10.1097/ACM.0000000000001233

M3 - Article

C2 - 27191837

AN - SCOPUS:84969179533

JO - Academic Medicine

JF - Academic Medicine

SN - 1040-2446

ER -